Patents by Inventor Giampaolo Tomasi

Giampaolo Tomasi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10646600
    Abstract: A method of use of an isolated polypeptide conjugated with a radionuclide, wherein the isolated polypeptide binds specifically to HER2, or a variant thereof is described. The method is for monitoring the response to HSP90 inhibition and comprises the use of the isolated polypeptide conjugated with 18F. The application also describes the use of an isolated polypeptide conjugated with 18F, wherein the isolated polypeptide binds specifically to HER2 or variants thereof, as an imaging agent to monitor uptake thereof to measure HSP90 inhibition.
    Type: Grant
    Filed: June 24, 2014
    Date of Patent: May 12, 2020
    Assignees: IMPERIAL INNOVATIONS LIMITED, GE HEALTHCARE LIMITED
    Inventors: Duncan Robert R. Hiscock, Eric Aboagye, Peter Iveson, Quang-De Nguyen, Susan Hoppmann, Sebastian Trousil, Maciej Kaliszczak, Giampaolo Tomasi
  • Publication number: 20160144062
    Abstract: A method of use of an isolated polypeptide conjugated with a radionuclide, wherein the isolated polypeptide binds specifically to HER2, or a variant thereof is described. The method is for monitoring the response to HSP90 inhibition and comprises the use of the isolated polypeptide conjugated with 18F. The application also describes the use of an isolated polypeptide conjugated with 18F, wherein the isolated polypeptide binds specifically to HER2 or variants thereof, as an imaging agent to monitor uptake thereof to measure HSP90 inhibition.
    Type: Application
    Filed: June 24, 2014
    Publication date: May 26, 2016
    Inventors: Ducan Robert R. HISCOCK, Eric Aboagye, Peter IVESON, Quang-De NGUYEN, Susan HOPPMANN, Sebastian TROUSIL, Maciej KALISZCZAK, Giampaolo TOMASI
  • Patent number: 6808800
    Abstract: A rigid polyurethane foam is described which is preferably, while not exclusively, used for manufacturing composite building elements used in buildings or for manufacturing industrial constructions. The foam has a structure consisting of closed cells substantially free therein of optionally halogenated hydrocarbon foaming agents, having an adhesion strength to a supporting substrate, measured according to standards EN 1607, equal to or higher than 0.7 kg/cm2. The polyurethane foam may be obtained starting from at least one polyol and at least one isocyanate compound by using a water-based foaming agent entirely compatible with the strictest environmental requirements, and has good mechanical characteristics, characteristics of dimensional stability, characteristics of adhesion to a supporting substrate and, possibly, characteristics of fire resistance.
    Type: Grant
    Filed: March 8, 2001
    Date of Patent: October 26, 2004
    Assignee: Sixton Holdings S.A.
    Inventor: Giampaolo Tomasi